Draegerwerk AG KGaAWBO:DRW8 -0.57%41 Buyback Yield % is 0.34 as of Jul. 13, 2026, which is 209% above its 10-year median of 0.11. GuruFocus rates WBO:DRW8 with a GF Score™ of 41/100 and a GF Value™ of €46.66 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 346 Medical Devices & Instruments companies, Draegerwerk AG KGaA ranks better than 71.68% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Draegerwerk AG KGaA Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Draegerwerk AG KGaA's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:DRW8 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Draegerwerk AG KGaA's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Draegerwerk AG KGaA Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Draegerwerk AG KGaA's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA (WBO:DRW8) has a Buyback Yield % of 0.34 as of Jul. 13, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Draegerwerk AG KGaA and its competitors. This is 209% above median its historical median of 0.11. According to the industry distribution chart, Draegerwerk AG KGaA ranks #98 out of 346 companies in the Medical Devices & Instruments industry, placing it in the top 28.3%.
Is Draegerwerk AG KGaA's Buyback Yield % too high?
Draegerwerk AG KGaA's current Buyback Yield % of 0.34 is 209% above median its 10-year median of 0.11. Based on the distribution chart, Draegerwerk AG KGaA ranks #98 out of 346 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Draegerwerk AG KGaA has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #98 out of 346 companies for Buyback Yield %. This puts Draegerwerk AG KGaA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Draegerwerk AG KGaA and its competitors. Draegerwerk AG KGaA's current Buyback Yield % is 0.34, which is 209% above median its own 10-year median of 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (WBO:DRW8) is currently considered Significantly Overvalued. The stock's GF Value™ is €46.66, compared to a current price of €69.40 — trading 48.7% above its estimated fair value. The current Buyback Yield % is 0.34, which is 209% above median its 10-year median of 0.11. Draegerwerk AG KGaA's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Draegerwerk AG KGaA (WBO:DRW8), the current Buyback Yield % is 0.34 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (WBO:DRW8) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of €69.40 is trading 48.7% above its estimated GF Value™ of €46.66.
GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.
Key valuation signals for WBO:DRW8:
Buyback Yield %: 0.34 (209% above median its 10-year median of 0.11)
GF Value™: €46.66 vs. price of €69.40 (48.7% above fair value)
No single metric tells the full story. See the WBO:DRW8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
41GF Score
Get the complete analysis for WBO:DRW8
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:DRW8 has been successfully added to your 
